We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Welcome to Episode #134 of the Value Investor Podcast
Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.
With stocks still rallying to start 2019, it’s been hard for value investors to find true value stocks.
The old price-to-earnings screens simply aren’t going to cut it in this type of market.
That’s why value investors have to take a fresh look at how they search for value stocks.
How Do You Screen for Value?
Most value investors simply use the P/E or the PEG when looking for value stocks. There’s nothing wrong with those screens.
But one of Tracey’s favorite value fundamentals is the price-to-sales (P/S) ratio.
A P/S ratio under 1.0 means that an investor is getting the sales on sale. Investors are paying less than the sales are worth for the sales.
The Secret Screen for Value
The secret screen includes a P/S ratio under 1.0 as well as the Zacks Rank of #1 (Strong Buy) and #2 (Buy). These should hopefully be stocks that are seeing rising earnings estimates.
We want only the best and the Zacks Rank allows us to narrow the universe.
This screen returned 176 stocks.
That’s a lot to dig into, so a market cap above $500 million was also added to exclude the microcaps.
The screen then returned 125 stocks.
That gave us plenty of choice.
5 Stocks with Attractive P/S Ratios
1. Allstate (ALL - Free Report) , the property insurer, has a P/S ratio of just 0.8. But it’s also cheap on a P/E basis, with a forward P/E of 10.2. Shares have been weak in 2019, falling 8.1% year-to-date. Could this be a buying opportunity?
2. Best Buy (BBY - Free Report) shares are down 12.8% year-to-date which has pushed them into the value category. It has a P/S ratio of just 0.4. It also pays a dividend, currently yielding 2.9%.
3. Sysco (SYY - Free Report) , the food distributor, has a P/S ratio of just 0.6. Earnings for fiscal 2019 are expected to rise 8.3% and another 10.4% in fiscal 2020. Investors also get a dividend, currently yielding 2.4%.
4. Walmart (WMT - Free Report) is cheap by a P/S ratio metric as it’s P/S is just 0.6. However, it’s forward P/E is on the high side, at 21. Do you buy the cheap sales even though you’re paying more for the earnings? Walmart does reward shareholders with a dividend yielding 2.1%.
5. Centene Corporation (CNC - Free Report) is a health insurer. The health insurers/HMOs have been hit hard in 2019 on fears of “Medicare-for-all” even though there is no actual legislation for it. Year-to-date, the shares are up just 2.4%. It’s cheap with a forward P/E of 14.2 and a P/S ratio of just 0.4. Earnings are also expected to rise 19.5% in 2019.
What else should you know about screening for value stocks in 2019?
Listen to this week’s podcast to find out.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
The Secret Value Stock Screen to Use Now
Welcome to Episode #134 of the Value Investor Podcast
Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.
With stocks still rallying to start 2019, it’s been hard for value investors to find true value stocks.
The old price-to-earnings screens simply aren’t going to cut it in this type of market.
That’s why value investors have to take a fresh look at how they search for value stocks.
How Do You Screen for Value?
Most value investors simply use the P/E or the PEG when looking for value stocks. There’s nothing wrong with those screens.
But one of Tracey’s favorite value fundamentals is the price-to-sales (P/S) ratio.
A P/S ratio under 1.0 means that an investor is getting the sales on sale. Investors are paying less than the sales are worth for the sales.
The Secret Screen for Value
The secret screen includes a P/S ratio under 1.0 as well as the Zacks Rank of #1 (Strong Buy) and #2 (Buy). These should hopefully be stocks that are seeing rising earnings estimates.
We want only the best and the Zacks Rank allows us to narrow the universe.
This screen returned 176 stocks.
That’s a lot to dig into, so a market cap above $500 million was also added to exclude the microcaps.
The screen then returned 125 stocks.
That gave us plenty of choice.
5 Stocks with Attractive P/S Ratios
1. Allstate (ALL - Free Report) , the property insurer, has a P/S ratio of just 0.8. But it’s also cheap on a P/E basis, with a forward P/E of 10.2. Shares have been weak in 2019, falling 8.1% year-to-date. Could this be a buying opportunity?
2. Best Buy (BBY - Free Report) shares are down 12.8% year-to-date which has pushed them into the value category. It has a P/S ratio of just 0.4. It also pays a dividend, currently yielding 2.9%.
3. Sysco (SYY - Free Report) , the food distributor, has a P/S ratio of just 0.6. Earnings for fiscal 2019 are expected to rise 8.3% and another 10.4% in fiscal 2020. Investors also get a dividend, currently yielding 2.4%.
4. Walmart (WMT - Free Report) is cheap by a P/S ratio metric as it’s P/S is just 0.6. However, it’s forward P/E is on the high side, at 21. Do you buy the cheap sales even though you’re paying more for the earnings? Walmart does reward shareholders with a dividend yielding 2.1%.
5. Centene Corporation (CNC - Free Report) is a health insurer. The health insurers/HMOs have been hit hard in 2019 on fears of “Medicare-for-all” even though there is no actual legislation for it. Year-to-date, the shares are up just 2.4%. It’s cheap with a forward P/E of 14.2 and a P/S ratio of just 0.4. Earnings are also expected to rise 19.5% in 2019.
What else should you know about screening for value stocks in 2019?
Listen to this week’s podcast to find out.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>